Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 192

Sort by

Sort Order Select

Journal Articles

Second Cancers in Adults with Acute Promyelocytic Leukemia (APL) Treated with or without Arsenic Trioxide (ATO): A SEER-Medicare Analysis

Kelly J. Norsworthy, MD, Steven T. Bird, PhD PharmD, MS, Armen Avagyan, MS, Yuchen Li, MS, Sandia Akhtar, BS, Jiemin Liao, MA, Michael Wernecke, BA, Albert B. Deisseroth, MD PhD, Meredith Chuk, MD, Thomas E. MaCurdy, PhD, Richard Swain, PhD, Jeffrey A. Kelman, MD MMSc, Ann T. Farrell, MD, Richard Pazdur, MD, Gideon Blumenthal, MD, David J. Graham, MD MPH

Blood (2019) 134 (Supplement_1): 3497.

https://doi.org/10.1182/blood-2019-130295

Published: 2019

Journal Articles

Comprehensive Characterization of Cytogenetic and Mutational Analysis of Acute Promyelocytic Leukemia: Is PML-Rara Everything?

Hassan Awada, MD, Jibran Durrani, Tariq Zuheir Kewan, MD, Ashwin Kishtagari, MBBS, Valeria Visconte, PhD, Reda Z. Mahfouz, MD PhD

Blood (2019) 134 (Supplement_1): 1404.

https://doi.org/10.1182/blood-2019-131724

Published: 2019

Journal Articles

Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia

Valentina Gaidano, MD, Paola Circosta, PhD, Alessandro Cignetti, MD PhD, Mohammad Houshmand, Nicoletta Vitale, PhD, Stefano Sainas, PhD, Agnese Pippione, PhD, Manuela Marraudino, PhD, Brigitta Bonaldo, MD, Marta Giorgis, PhD, Donatella Boschi, PhD, Marco Lucio Lolli, PhD, Giuseppe Saglio, MD

Blood (2019) 134 (Supplement_1): 3942.

https://doi.org/10.1182/blood-2019-128085

Published: 2019

Journal Articles

Oral Arsenic Trioxide, ATRA and Ascorbic Acid (AAA) Maintenance Following First Complete Remission in Acute Promyelocytic Leukemia - Long-Term Data and Unique Prognostic Indicators

Harinder Gill, FRCP, FRCPath, Rita Yim, PhD, Cyrus R Kumana, FRCP, Yok-Lam Kwong, MD

Blood (2019) 134 (Supplement_1): 3853.

https://doi.org/10.1182/blood-2019-125185

Published: 2019

Journal Articles

Pilot Study of Oral Realgar-Indigo Naturalis Formula in Pediatric Acute Promyelocyticleukemia: Effectiveness and Population Pharmacokinetics

Li Zhang, Xin-mei Yang, Jing Chen, Lei Hu, Fan Yang, Yue Zhou, Bei-bei Zhao, Wei Zhao, Xiao-fan Zhu, PhD

Blood (2019) 134 (Supplement_1): 5084.

https://doi.org/10.1182/blood-2019-122876

Published: 2019

Journal Articles

Outcomes of Hematopoietic Cell Transplantation in Acute Promyelocytic Leukemia - a Single Institution Experience

Hamza Hashmi, MD, Jeffrey Lancet, MD, Asmita Mishra, MD, Kendra L. Sweet, MD, Rami S. Komrokji, MD, Hugo F. Fernandez, MD, Lia Perez, MD, Farhad Khimani, MD, Michael Nieder, MD, Hany Elmariah, MD MS, Joseph Pidala, MD, Nelli Bejanyan, MD, Alan F. List, MD, Claudio Anasetti, MD, Taiga Nishihori, MD

Blood (2019) 134 (Supplement_1): 5739.

https://doi.org/10.1182/blood-2019-128985

Published: 2019

Journal Articles

Pilot Study on the Safety of Intravenous Arsenic Trioxide and Oral Realgar-Indigo Naturalis Formula Administrated in Children with Acute Promyelocytic Leukemia: A Single-Center Study

Linya Wang, MD, Yuanyuan Zhang, MD, Ruidong Zhang, MD PhD, Jiaole Yu, PhD MD, Ying Wu, MD, Wei Lin, Peijing Qi, Jia Fan, Jing Li, PhD, Jiayan Lin, Xueling Zheng, Hairu Hu, Xiaoxia Peng, Hui Jiang, PhD, Huyong Zheng, MD PhD

Blood (2019) 134 (Supplement_1): 2611.

https://doi.org/10.1182/blood-2019-128196

Published: 2019

Journal Articles

Oral arsenic for acute promyelocytic leukemia

Blood (2019) 134 (7): 659.

https://doi.org/10.1182/blood.2019002409

Published: 2019

Journal Articles

The simpler, the better: oral arsenic for acute promyelocytic leukemia

Hong-Hu Zhu, Jiong Hu, Francesco Lo-Coco, Jie Jin

Blood (2019) 134 (7): 597–605.

https://doi.org/10.1182/blood.2019000760

Published: 2019

Includes: Supplemental data

Journal Articles

Arsenic and old FLT3

Mark Levis

Blood (2019) 133 (13): 1392–1393.

https://doi.org/10.1182/blood-2019-02-899286

Published: 2019

Journal Articles

FLT3 -ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias

Cécile Esnault, Ramy Rahmé, Kim L. Rice, Caroline Berthier, Coline Gaillard, Samuel Quentin, Anne-Lise Maubert, Scott Kogan, Hugues de Thé

Blood (2019) 133 (13): 1495–1506.

https://doi.org/10.1182/blood-2018-07-866095

Published: 2019

Includes: Supplemental data

Journal Articles

A Long-Term Retrospective Analysis of Arsenic-Containing Triple-Agents Treatment for Acute Promyelocytic Leukemia (APL) in a Cohort from a Single Hospital

Xian Zhang, PhD, Junfang Yang, MD, Fanyong LV, Gailing Zhang, MD, Yunchao Su, MD, Peihua Lu

Blood (2018) 132 (Supplement 1): 4060.

https://doi.org/10.1182/blood-2018-99-117795

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Richard Dillon, MA, PhD MRCP, FRCPath, Jelena Jovanovic, PhD, Nicola Potter, PhD, Nicola Foot, MSc, Matthew J Ahearne, MD MBBS, Sandrine Jayne, PhD, Michael Dennis, MD MRCP, FRCPath, Ann E. Hunter, MBBS, FRCP, FRCPath, Martin J.S. Dyer, Paresh Vyas, Lynn Quek, FRCPath, DPhil, MBBS, Nigel H. Russell, Robert K. Hills, MA, DPhil, MSc, Ellen Solomon, PhD, David Grimwade, PhD MRCP, MRCPath

Blood (2018) 132 (Supplement 1): 2570.

https://doi.org/10.1182/blood-2018-99-114233

Published: 2018

Journal Articles

Oral Arsenic Trioxide in the Frontline Treatment of Newly-Diagnosed Acute Promyelocytic Leukemia: A 5-Year Prospective Cohort Study

Harinder Gill, MBBS, MRCP, FRCP, Cyrus R Kumana, FRCP, Yok-Lam Kwong, MD

Blood (2018) 132 (Supplement 1): 3990.

https://doi.org/10.1182/blood-2018-99-111801

Published: 2018

Journal Articles

Novel Fusion Genes Involving Hnrnpc and Rarg in Acute Myeloid Leukemia Mimicking Acute Promyelocytic Leukemia

Zhan Su, MD, Xin Liu, MD PhD, Yan Xu, MD, Weiyu Hu, MD, Chunting Zhao, MD, Hongguo Zhao, MD, Xianqi Feng, MD, Shuchao Zhang, Jie Yang, Xue Shi, Lugui Qiu, MD PhD, Jun Peng, MD PhD

Blood (2018) 132 (Supplement 1): 5274.

https://doi.org/10.1182/blood-2018-99-111433

Published: 2018

Journal Articles

Acute Promyelocytic Leukemia: Clinical Outcomes, Induction Deaths and Challenges

Tara Rajendran, MBBS, Krishna Prasad, MBBS, MD(MDcine), DM (Oncology)

Blood (2018) 132 (Supplement 1): 5191.

https://doi.org/10.1182/blood-2018-99-116705

Published: 2018

Journal Articles

Omission of Maintenance in Patients with High-Risk Acute Promyelocytic Leukemia (APL) in the Era of ATRA/Arsenic Consolidation

Gaurav Shah, MD, Fady M. Mikhail, MD PhD, Harry P. Erba, MD PhD, Nikolaos Papadantonakis, MD PhD MSc

Blood (2018) 132 (Supplement 1): 5192.

https://doi.org/10.1182/blood-2018-99-114872

Published: 2018

Journal Articles

Specific and Synergistic Targeting of JAK2V617F Cells By Interferon Alpha and Arsenic

Nabih Maslah1, PharmD, Tracy Dagher, PhDstudent, Valérie Edmond, PhD, Bruno Cassinat, PharmD, PhD, Valérie Lallemand-Breitenbach, PhD, Emmanuelle Verger, PhD, Isabelle Plo, PhD, Jean-Jacques Kiladjian, MD PhD, Jean-Luc Villeval, PhD, Hugues de Thé, MD PhD

Blood (2018) 132 (Supplement 1): 52.

https://doi.org/10.1182/blood-2018-99-112518

Published: 2018

Journal Articles

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Hong-Hu Zhu, Yan-Rong Liu, Jin-Song Jia, Ya-Zhen Qin, Xiao-Su Zhao, Yue-Yun Lai

Blood (2018) 131 (26): 2987–2989.

https://doi.org/10.1182/blood-2018-02-834051

Published: 2018

Includes: Supplemental data

Journal Articles

Oral Arsenic Plus Retinoic Acid Versus Intravenous Arsenic Plus Retinoic Acid for Non-High Risk Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trials

Honghu Zhu, Depei Wu, MD, Xi Zhang, MD PhD, Lin LIU, Jun Ma, Zonghong Shao, MD, Hanyun Ren, MDPhD, Jianda Hu, Prof MDPhD, Kailin Xu, MD, PhD, Jing-Wen Wang, Yongping Song, Mei-Yun Fang, Xiao-Jun Huang, MD

Blood (2017) 130 (Supplement 1): 641.

https://doi.org/10.1182/blood.V130.Suppl_1.641.641

Published: 2017

NARROW

Second Cancers in Adults with Acute Promyelocytic Leukemia (APL) Treated with or without Arsenic Trioxide (ATO): A SEER-Medicare Analysis

Comprehensive Characterization of Cytogenetic and Mutational Analysis of Acute Promyelocytic Leukemia: Is PML-Rara Everything?

Meds433, a New Dihydroorotate Dehydrogenase Inhibitor, Induces Apoptosis and Differentiation in Acute Myeloid Leukemia

Oral Arsenic Trioxide, ATRA and Ascorbic Acid (AAA) Maintenance Following First Complete Remission in Acute Promyelocytic Leukemia - Long-Term Data and Unique Prognostic Indicators

Pilot Study of Oral Realgar-Indigo Naturalis Formula in Pediatric Acute Promyelocyticleukemia: Effectiveness and Population Pharmacokinetics

Outcomes of Hematopoietic Cell Transplantation in Acute Promyelocytic Leukemia - a Single Institution Experience

Pilot Study on the Safety of Intravenous Arsenic Trioxide and Oral Realgar-Indigo Naturalis Formula Administrated in Children with Acute Promyelocytic Leukemia: A Single-Center Study

Oral arsenic for acute promyelocytic leukemia

The simpler, the better: oral arsenic for acute promyelocytic leukemia

Arsenic and old FLT3

FLT3 -ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias

A Long-Term Retrospective Analysis of Arsenic-Containing Triple-Agents Treatment for Acute Promyelocytic Leukemia (APL) in a Cohort from a Single Hospital

Therapy-Related Myeloid Neoplasms with Balanced Chromosome Rearrangements Frequently Arise from Pre-Existing Clonal Haematopoiesis

Oral Arsenic Trioxide in the Frontline Treatment of Newly-Diagnosed Acute Promyelocytic Leukemia: A 5-Year Prospective Cohort Study

Novel Fusion Genes Involving Hnrnpc and Rarg in Acute Myeloid Leukemia Mimicking Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia: Clinical Outcomes, Induction Deaths and Challenges

Omission of Maintenance in Patients with High-Risk Acute Promyelocytic Leukemia (APL) in the Era of ATRA/Arsenic Consolidation

Specific and Synergistic Targeting of JAK2V617F Cells By Interferon Alpha and Arsenic

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Oral Arsenic Plus Retinoic Acid Versus Intravenous Arsenic Plus Retinoic Acid for Non-High Risk Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trials

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only